Pons P; Rodriguez M; Robaina C; Illnait J; Mas R; Fernandez L; Fernandez JC. (1994). “Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment”. 《International Journal of Clinical Pharmacology Research》 14 (1): 27–33. PMID7927958.
Chen JT; Wesley R; Shamburek RD; Pucino F; Csako G (2005). “Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol”. 《Pharmacotherapy》 25 (2): 171–83. doi:10.1592/phco.25.2.171.56942. PMID15767233.
Liu, S.; Tan, M. Y.; Zhao, S. P.; Rong, H. (2012). “Effects of policosanol on serum lipids and heme oxygenase-1 in patients with hyperlipidemia”. 《Zhonghua xin xue guan bing za zhi》 40 (10): 840–843. PMID23302671.
Zanardi, M.; Quirico, E.; Benvenuti, C.; Pezzana, A. (2012). “Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancer”. 《Minerva ginecologica》 64 (5): 431–435. PMID23018482.